Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Toxicon ; 56(4): 487-96, 2010 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-20493199

RESUMO

A new vasoactive cytolytic toxin, referred to as Sp-CTx, has been purified from the venom of the scorpionfish Scorpaena plumieri by a combination of gel filtration and anion exchange chromatographies. An estimation of Sp-CTx native molecular mass, performed by size exclusion chromatography, demonstrated that it is a 121 kDa protein. Further physicochemical studies revealed its glycoproteic nature and dimeric constitution, comprising subunits of approximately 65 kDa (MALDI-TOF-MS). Such protein has proved to possess a potent hemolytic activity on washed rabbit erythrocytes (EC(50) 0.46 nM), whose effect was strongly reduced after treatment with antivenom raised against stonefish venom -Synanceja trachynis (SFAV). This cross-reactivity has been confirmed by western blotting. Like S. plumieri whole venom (100 microg/mL), Sp-CTx (1-50 nM) caused a biphasic response on phenylephrine pre-contracted rat aortic rings, characterized by an endothelium- and dose-dependent relaxation phase followed by a contractile phase. The vasorelaxant activity has been abolished by l-NAME, demonstrating the involvement of nitric oxide on the response. We report here the first isolation of a cytolytic/vasoactive protein from scorpionfish venom and the data provided suggest structural and functional similarities between Sp-CTx and previously published stonefish hemolytic toxins.


Assuntos
Citotoxinas/química , Venenos de Peixe/química , Peixes Venenosos , Hemolíticos/química , Vasodilatadores/química , Animais , Aorta/efeitos dos fármacos , Citotoxinas/isolamento & purificação , Citotoxinas/toxicidade , Eritrócitos/efeitos dos fármacos , Venenos de Peixe/isolamento & purificação , Venenos de Peixe/toxicidade , Hemolíticos/isolamento & purificação , Hemolíticos/toxicidade , Técnicas In Vitro , Contração Miocárdica/efeitos dos fármacos , Coelhos , Ratos , Vasodilatadores/isolamento & purificação , Vasodilatadores/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...